Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorNombre químico: (2S,4R)-1-(9-Fluorenylmethyloxycarbonyl)-4-tritylmercapto-pyrrolidine-2-carboxylic acid // Sinónimos: (2S,4R)-Fmoc-4-tritylmercapto-pyrrolidine-2-carboxylic acid, Fmoc-4-tritylmercapto-L-proline (2S,4R), (2S,4R)-Fmoc-Mpc(Trt)-OH, Fmoc-Pro(4-STrt)-OH (2S,4R)
from 350,00 €
4-Mercaptoproline, a hybrid, or chimeric amino acid which combines the properties of proline and homocysteine. It can be used for disulfide bridge formation with defined sterical orientation. This building block has also been used for multiple controlled native chemical ligations.
Multiple Binding Modes for the Receptor-Bound Conformations of Cyclic AII Agonists; Krystina Plucinska, Takahiro Kataoka, Mitsuaki Yodo, Wayne L. Cody, J. X. He, Christine Humblet, G. H. Lu, Elizabeth Lunney, Terry C. Major, Robert L. Panek, Pamela Schelkun, Richard Skeean, and
Garland R. Marshall; J. Med. Chem. 1998; 36: 1902-1913.
Novel Cyclic Analogs of Angiotensin II with Cyclization between Positions 5 and 7: Conformational and Biological Implications; Wei-Jun Zhang, Gregory V. Nikiforovich, Jacqueline Pérodin, Darren E. Richard, Emanuel Escher, and Garland R. Marshall, J. Med. Chem. 1996; 39: 2738-2744.
Dual Kinetically Controlled Native Chemical Ligation Using a Combination of Sulfanylproline and Sulfanylethylanilide Peptide; Hao Ding, Akira Shigenaga, Kohei Sato, Ko Morishita, and Akira Otaka;
Org. Lett. 2011; 13(20): 5588-5591. DOI 10.1021/ol202316v.
Por favor envíeme más información sobre